ANALYSIS: Kiwi SaaS giant is paying up to gain better access to the US market, in an example of boldness rarely seen from New Zealand companies.
Partners Life's massive $1b sale should be celebrated, but has left some wondering what could have been.
ANALYSIS: Bloody-minded officials put kibosh yet again on mandatory new-build warranties.
ANALYSIS: The Bioplant group and its offshore partners mum on financing of Manawatū waste-to-energy project.
ANALYSIS: With eight months down, 2022 not looking like a good year for a float.
ANALYSIS: Is Zuru a corporate bullyboy, or is defamation action against former employees a sign of a maturing internet?
ANALYSIS: Promoting high-risk offers on Facebook and Instagram seems here to stay, so is more disclosure required?
ANALYSIS: Why Kiwi companies are flocking to set up US hubs in Denver.
Under duress the supermarket duopoly is transforming – but aims to retain its invisible hand.
ANALYSIS: Rocket Lab's share price has crashed since listing, but there are reasons for optimism.